1589. Ceftolozane–Tazobactam Activity Against Difficult-to-Treat Resistance in Pseudomonas aeruginosa from Bloodstream Infections in US Hospitals

BACKGROUND: Infections caused by Pseudomonas aeruginosa (PSA) resistant to first-line agents are difficult to treat and require using more toxic antimicrobials, such as amikacin (AMK) and colistin (COL). Kadri et al. recently described the category of difficult-to-treat resistance (DTR) as intermedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shortridge, Dee, Ryan Arends, S J, Duncan, Leonard R, Streit, Jennifer M, Flamm, Robert K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810805/
http://dx.doi.org/10.1093/ofid/ofz360.1453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810805/
http://dx.doi.org/10.1093/ofid/ofz360.1453

Ejemplares similares